Health Care Innovation
Featured
NEW BRIEF: Expanding “Buy America” Rules Would Hurt U.S. Patients and Economy, Hinder Development of Coronavirus Vaccine
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. ...
Coronavirus
The Pat Miller Show Talks to Sally C. Pipes on Private Sector Role in Coronavirus Fight
Sally C. Pipes joined the the Pat Miller Show in Cincinnati, Ohio to discuss the enormous benefits of the American private sector in the fight against the coronavirus epidemic. Pipes breaks down how the private sector industries in the United States are pushing innovations in the fight against the coronavirus ...
Commentary
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from ...
Drug Pricing
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
Commentary
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
Blog
Single Payer Poll Watch: Coronavirus Update
Coronavirus is impacting everything and anything it touches. In the March PRI Single Payer Poll Watch, average opposition to a single payer plan overtook support, continuing the trend of growing opposition to a single payer health care plan PRI noticed in our first poll watch in December 2019. With the ...
Commentary
As Coronavirus Spreads, Private Sector Offers Hope—And Treatments
Optimism is in short supply as the coronavirus pandemic grows deadlier by the day. COVID-19 has taken thousands of lives around the world and upended nearly every aspect of daily life. But there is at least one bright spot in this global public health emergency. That’s the astounding speed with ...
Drug Importation
New Animated Series Aims to Help Patients “Escape the Drug Pricing Maze”
SAN FRANCISCO – As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched today by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing ...
Commentary
Coronavirus shows why you don’t want price controls during a pandemic
The World Health Organization has declared the novel coronavirus a global pandemic, with more than 118,000 confirmed cases worldwide. As countries brace for the worst, people around the world are looking to the United States for a drug that can prevent or cure the disease. The world is right to put its ...
Featured
NEW ISSUE BRIEF: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs By 17 Percent
Expanding the use of biosimilars to treat serious illnesses like cancer or auto-immune diseases could reduce a patient’s out-of-pocket costs by 17 percent, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the study “Biologics ...
NEW BRIEF: Expanding “Buy America” Rules Would Hurt U.S. Patients and Economy, Hinder Development of Coronavirus Vaccine
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. ...
The Pat Miller Show Talks to Sally C. Pipes on Private Sector Role in Coronavirus Fight
Sally C. Pipes joined the the Pat Miller Show in Cincinnati, Ohio to discuss the enormous benefits of the American private sector in the fight against the coronavirus epidemic. Pipes breaks down how the private sector industries in the United States are pushing innovations in the fight against the coronavirus ...
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from ...
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
Single Payer Poll Watch: Coronavirus Update
Coronavirus is impacting everything and anything it touches. In the March PRI Single Payer Poll Watch, average opposition to a single payer plan overtook support, continuing the trend of growing opposition to a single payer health care plan PRI noticed in our first poll watch in December 2019. With the ...
As Coronavirus Spreads, Private Sector Offers Hope—And Treatments
Optimism is in short supply as the coronavirus pandemic grows deadlier by the day. COVID-19 has taken thousands of lives around the world and upended nearly every aspect of daily life. But there is at least one bright spot in this global public health emergency. That’s the astounding speed with ...
New Animated Series Aims to Help Patients “Escape the Drug Pricing Maze”
SAN FRANCISCO – As prescription drug pricing and accessibility has become a greater topic of discussion during the current coronavirus pandemic, a new series of animated videos launched today by the Center for Medical Economics and Innovation at the Pacific Research Institute aims to guide Americans through the “drug pricing ...
Coronavirus shows why you don’t want price controls during a pandemic
The World Health Organization has declared the novel coronavirus a global pandemic, with more than 118,000 confirmed cases worldwide. As countries brace for the worst, people around the world are looking to the United States for a drug that can prevent or cure the disease. The world is right to put its ...
NEW ISSUE BRIEF: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs By 17 Percent
Expanding the use of biosimilars to treat serious illnesses like cancer or auto-immune diseases could reduce a patient’s out-of-pocket costs by 17 percent, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the study “Biologics ...
